Elisabeth F Beaber

发表

Variation in Mammographic Breast Density Assessments Among Radiologists in Clinical Practice: A Multicenter Observational Study.

Ronilda C. Lacson, Despina Kontos, Donald L Weaver, 2016, Annals of internal medicine.

Unifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screening.

Donald L Weaver, Jasmin A Tiro, Ann G Zauber, 2015, Journal of the National Cancer Institute.

Breast cancer screening using tomosynthesis in combination with digital mammography compared to digital mammography alone: a cohort study within the PROSPR consortium

Anne Marie McCarthy, Donald L Weaver, Katrina Armstrong, 2016, Breast Cancer Research and Treatment.

Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda.

E. Halm, Malia M Oliver, R. Greenlee, 2022, Cancer Epidemiology, Biomarkers and Prevention.

Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines

J. Haas, Yingye Zheng, C. Skinner, 2022, Annals of Internal Medicine.

Multilevel Predictors of Continued Adherence to Breast Cancer Screening Among Women Ages 50-74 Years in a Screening Population.

C. Lehman, A. Tosteson, W. Barlow, 2019, Journal of women's health.

Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines

J. Haas, Yingye Zheng, C. Skinner, 2022, Annals of Internal Medicine.

Reproductive Factors, Age at Maximum Height, and Risk of Three Histologic Types of Breast Cancer

P. Porter, K. Malone, J. Daling, 2008, Cancer Epidemiology Biomarkers & Prevention.

Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20 to 44 years of age.

P. Porter, K. Malone, J. Daling, 2012, Cancer research.

Receipt of Colonoscopy Following Diagnosis of Advanced Adenomas: An Analysis within Integrated Healthcare Delivery Systems

E. Halm, A. Zauber, Chyke A Doubeni, 2018, Cancer Epidemiology, Biomarkers & Prevention.

Oral Contraceptives and Breast Cancer Risk Overall and by Molecular Subtype Among Young Women

P. Porter, W. Barlow, K. Malone, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Use of oral contraceptives (OC) and breast cancer risk among young women by OC formulation and breast cancer subtype

Elisabeth F. Beaber, Elisabeth F Beaber, 2012 .

Evaluating Lung Cancer Screening Across Diverse Healthcare Systems: A Process Model from the Lung PROSPR Consortium

Chyke A Doubeni, M. Schnall, R. Greenlee, 2019, Cancer Prevention Research.

Risk among Women 20 to 44 Years of Age Effect of Depo-Medroxyprogesterone Acetate on Breast Cancer

P. Porter, K. Malone, J. Daling, 2012 .

Evaluating screening participation, follow-up and outcomes for breast, cervical and colorectal cancer in the PROSPR consortium.

Jasmin A. Tiro, E. Halm, A. Zauber, 2019, Journal of the National Cancer Institute.

Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium

Jasmin A. Tiro, E. Halm, C. Wheeler, 2016, Journal of General Internal Medicine.

Provider Attitudes and Screening Practices Following Changes in Breast and Cervical Cancer Screening Guidelines

A. Tosteson, T. Onega, J. Haas, 2015, Journal of General Internal Medicine.

Inadequate Systems to Support Breast and Cervical Cancer Screening in Primary Care Practice

Jennifer S. Haas, Marilyn M. Schapira, Brian L. Sprague, 2016, Journal of General Internal Medicine.

Breast cancer screening in an era of personalized regimens: A conceptual model and National Cancer Institute initiative for risk‐based and preference‐based approaches at a population level

E. Conant, A. Tosteson, W. Barlow, 2014, Cancer.

Cervical cancer screening research in the PROSPR I consortium: Rationale, methods and baseline findings from a US cohort

Jasmin A. Tiro, C. Wheeler, C. Skinner, 2018, International journal of cancer.

Communication Practices of Mammography Facilities and Timely Follow-up of a Screening Mammogram with a BI-RADS 0 Assessment.

E. Conant, A. Tosteson, W. Barlow, 2018, Academic radiology.

Primary Care Providers’ Beliefs and Recommendations and Use of Screening Mammography by their Patients

A. Tosteson, W. Barlow, T. Onega, 2017, Journal of General Internal Medicine.

Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/Ethnicity.

E. Conant, Chyke A Doubeni, M. Schnall, 2016, American journal of preventive medicine.

Influence of Age and Comorbidity on Colorectal Cancer Screening in the Elderly.

E. Halm, Chyke A Doubeni, C. Rutter, 2016, American journal of preventive medicine.

Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach

E. Halm, Chyke A Doubeni, C. Rutter, 2016, Journal of General Internal Medicine.

Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20–44 years of age

P. Porter, K. Malone, J. Daling, 2012, Breast Cancer Research and Treatment.

Breast cancer screening initiation after turning 40 years of age within the PROSPR consortium

A. Zauber, Chyke A Doubeni, A. Tosteson, 2016, Breast Cancer Research and Treatment.

Time to Follow-up After Colorectal Cancer Screening by Health Insurance Type.

Chyke A Doubeni, J. Haas, Yingye Zheng, 2019, American journal of preventive medicine.

Provider- and Facility-Level Variation in Precancerous Cervical Biopsy Diagnoses

C. Wheeler, T. Raine-Bennett, D. Corley, 2023, Journal of lower genital tract disease.

Association of Digital Breast Tomosynthesis vs Digital Mammography With Cancer Detection and Recall Rates by Age and Breast Density

Natasha K. Stout, Donald L. Weaver, Emily F. Conant, 2019, JAMA oncology.

De-implementation of cervical cancer screening before age 21.

Jasmin A. Tiro, J. Haas, C. Skinner, 2021, Preventive medicine.

Recent oral contraceptive use by formulation and breast cancer risk among women 20 to 49 years of age.

D. Buist, W. Barlow, S. Reed, 2014, Cancer research.

Gaps in the screening process for women diagnosed with cervical cancer in four diverse US health care settings

C. Wheeler, C. Skinner, T. Raine-Bennett, 2022, Cancer Medicine.

Challenges With Identifying Indication for Examination in Breast Imaging as a Key Clinical Attribute in Practice, Research, and Policy.

M. Synnestvedt, A. Tosteson, T. Onega, 2017, Journal of the American College of Radiology : JACR.

Variation inMammographic Breast Density Assessments Among Radiologists in Clinical Practice AMulticenter Observational Study

Ronilda C. Lacson, E. Conant, D. Kontos, 2016 .

Oral Contraceptives and Breast Cancer Risk Overall and by Molecular Subtype Among Young Women

P. Porter, W. Barlow, K. Malone, 2014, Cancer Epidemiology, Biomarkers & Prevention.